文献速递临床试验与 GCP流行病学与生物统计

定制数字依从性工具对坦桑尼亚哺乳期女性、儿童和青少年HIV感染者护理保持及抗逆转录病毒治疗依从性的影响:一项混合方法研究及随后的临床试验

Effect of a customized digital adherence tool on retention in care and adherence to antiretroviral treatment in breastfeeding women, children and adolescents living with HIV in Tanzania: a mixed-methods study followed by clinical trials.
PubMed 文献 · Trials · 2023-04-21

该研究计划在坦桑尼亚乞力马扎罗和阿鲁沙地区开展形成性混合方法研究及三项子试验,定制Wisepill数字依从性工具并联合提醒短信与定制反馈,评估其对儿童和青少年HIV感染者抗逆转录病毒治疗依从性及哺乳期女性护理保持的效果。若干预能改善依从性且设备可接受、准确、可持续,可在国家艾滋病控制规划内推广。

要点

  • WHO推荐使用数字依从性技术(DATs),但DATs改善依从性的证据有限。
  • Wisepill®在多项研究中可行且可接受,但其改善ART依从性的有效性证据有限。
  • 研究将在乞力马扎罗和阿鲁沙地区开展形成性混合方法研究及三项子试验。

核心结论

  • 若干预能改善ART依从性且设备可接受、准确、可持续,该干预可在国家艾滋病控制规划内推广。

研究设计与样本

  • 两阶段项目:形成性混合方法研究定制Wisepill DAT干预,随后开展随机临床试验。
  • 在乞力马扎罗和阿鲁沙地区开展三项子试验,对象为0-14岁儿童及其照护者、15-19岁青少年、哺乳期女性及其HIV阴性婴儿。
  • 试验中参与者随机分配至干预组(实施DAT)或对照组(标准护理)。
  • 干预组参与者从Wisepill药盒取药,并接受每日提醒短信及就诊时定制反馈。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adherence to antiretroviral (ARV) treatment for HIV infection is challenging because of many factors. The World Health Organization (WHO) has recommended using digital adherence technologies (DATs). However, there is limited evidence on how DATs improve adherence. Wisepill® is an internet-enabled medication dispenser found feasible and acceptable in several studies. However, limited evidence is available on its effectiveness in improving ART adherence, specifically among children and adolescents. Furthermore, DATs are often developed without involving the target groups. We propose a two-stage project consisting of a formative study to customize an existing Wisepill DAT intervention and a randomized clinical trial to investigate the effectiveness of DAT combined with reminder cues and tailored feedback on adherence to ARV treatment among children and adolescents living with HIV and retention in care among breastfeeding women living with HIV in Kilimanjaro and Arusha Region, Tanzania. METHODS: We will conduct a formative mixed-methods study and three sub-trials in Kilimanjaro and Arusha Regions among (1) children aged 0-14 years and their caregivers, (2) adolescents aged 15-19 years and (3) breastfeeding women and their HIV-negative infants. In the formative study, we will collect and analyse data on needs and contents for DATs, including the contents of short message service (SMS) texts and tailored feedback. The results will inform the customization of the DAT to be tested in the sub-trials. In the trials, participants will be randomized in the intervention arm, where the DAT will be implemented or the control arm, where standard care will be followed. Participants in the intervention arm will take their medication from the Wisepill box and receive daily reminder texts and tailored feedback during clinic visits. DISCUSSION: If the intervention improves adherence to ART and the devices are acceptable, accurate and sustainable, the intervention can be scaled up within the National Aids Control Programmes. TRIAL REGISTRATION: PACTR202301844164954, date 27 January 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Sumari-de Boer IM, Ngowi KM, Swai IU, et al. Effect of a customized digital adherence tool on retention in care and adherence to antiretroviral treatment in breastfeeding women, children and adolescents living with HIV in Tanzania: a mixed-methods study followed by clinical trials. Trials. 2023. PMID: 37085913. doi:10.1186/s13063-023-07293-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。